Ayodele Olajide Falase

Last updated
Ayodele Olajide Falase
Born
Ayodele Olajide Falase

4 January 1944
Osun, Nigeria
Nationality Nigerian
Alma materIgbobi College, Yaba

Royal College of Physicians and Surgeons of Canada National Postgraduate Medical College of Nigeria

Contents

University of Ibadan (MBBS)
Scientific career
Fields Cardiology
Institutions WHO

Ayodele Olajide Falase (born 4 January 1944) is a Nigerian cardiologist and academic. He is a former vice chancellor of the University of Ibadan. [1] He served as a WHO Expert committee member on cardiopathies and on a WHO expert panel on cardiovascular disease. [2] Professor Ayodele Falase got the Honorary fellowship award at the University of Ibadan 71st founder’s day held in 2019. [3]

Early life

Ayodele was born on 4 January 1944 in the village of Erin-Oke, Oriade local government of Osun state, Nigeria.

Ayodele completed his education in the following schools: [2]

Career

Ayodele started his career at University College Hospital, Ibadan in 1968-69, immediately after graduation from the same university. He became a house physician in 1969-70 and a registrar in 1971-72, in the same college hospital. He held several positions on this career path until he rose to become a professor of cardiology and founder of Pan African Society of Cardiology (PASCAR). [4] He was awarded the Nigerian National Merit Award in 2005 and currently one of the four Emeritus Professors at the Department of Medicine, University of Ibadan. [5] [6] An Introduction to Clinical Diagnosis in the Tropics, a popular clinical clerkship book among Nigerian clinical medical students was first published by him in 1986. [7]

Research

Ayodele's publications include subjects on:

Books

The human heart fountain of life: inaugural lecture delivered on Tuesday 27 January 1981

An introduction to clinical diagnosis in the tropics(1986) [23]

Cardiovascular disease(1987)

Related Research Articles

<span class="mw-page-title-main">Cardiology</span> Branch of medicine dealing with the heart

Cardiology is the study of the heart. Cardiology is a branch of medicine that deals with disorders of the heart and the cardiovascular system. The field includes medical diagnosis and treatment of congenital heart defects, coronary artery disease, heart failure, valvular heart disease, and electrophysiology. Physicians who specialize in this field of medicine are called cardiologists, a specialty of internal medicine. Pediatric cardiologists are pediatricians who specialize in cardiology. Physicians who specialize in cardiac surgery are called cardiothoracic surgeons or cardiac surgeons, a specialty of general surgery.

<span class="mw-page-title-main">Hypertension</span> Long-term high blood pressure in the arteries

Hypertension, also known as high blood pressure, is a long-term medical condition in which the blood pressure in the arteries is persistently elevated. High blood pressure usually does not cause symptoms. It is, however, a major risk factor for stroke, coronary artery disease, heart failure, atrial fibrillation, peripheral arterial disease, vision loss, chronic kidney disease, and dementia. Hypertension is a major cause of premature death worldwide.

<span class="mw-page-title-main">Heart failure</span> Failure of the heart to provide sufficient blood flow

Heart failure (HF), also known as congestive heart failure (CHF), is a syndrome, a group of signs and symptoms, caused by an impairment of the heart's blood pumping function. Symptoms typically include shortness of breath, excessive fatigue, and leg swelling. The shortness of breath may occur with exertion or while lying down, and may wake people up during the night. Chest pain, including angina, is not usually caused by heart failure, but may occur if the heart failure was caused by a heart attack. The severity of the heart failure is mainly decided based on ejection fraction and also measured by the severity of symptoms. Other conditions that may have symptoms similar to heart failure include obesity, kidney failure, liver disease, anemia, and thyroid disease.

<span class="mw-page-title-main">Myocarditis</span> Inflammation of the heart muscle

Myocarditis, also known as inflammatory cardiomyopathy, is an acquired cardiomyopathy due to inflammation of the heart muscle. Symptoms can include shortness of breath, chest pain, decreased ability to exercise, and an irregular heartbeat. The duration of problems can vary from hours to months. Complications may include heart failure due to dilated cardiomyopathy or cardiac arrest.

Hypertrophic cardiomyopathy is a condition in which muscle tissues of the heart become thickened without an obvious cause. The parts of the heart most commonly affected are the interventricular septum and the ventricles. This results in the heart being less able to pump blood effectively and also may cause electrical conduction problems. Specifically, within the bundle branches that conduct impulses through the interventricular septum and into the Purkinje fibers, as these are responsible for the depolarization of contractile cells of both ventricles.

Antihypertensives are a class of drugs that are used to treat hypertension. Antihypertensive therapy seeks to prevent the complications of high blood pressure, such as stroke, heart failure, kidney failure and myocardial infarction. Evidence suggests that reduction of the blood pressure by 5 mmHg can decrease the risk of stroke by 34% and of ischaemic heart disease by 21%, and can reduce the likelihood of dementia, heart failure, and mortality from cardiovascular disease. There are many classes of antihypertensives, which lower blood pressure by different means. Among the most important and most widely used medications are thiazide diuretics, calcium channel blockers, ACE inhibitors, angiotensin II receptor antagonists (ARBs), and beta blockers.

<span class="mw-page-title-main">Left ventricular hypertrophy</span> Medical condition

Left ventricular hypertrophy (LVH) is thickening of the heart muscle of the left ventricle of the heart, that is, left-sided ventricular hypertrophy and resulting increased left ventricular mass.

<span class="mw-page-title-main">Hypertensive emergency</span> Profoundly elevated blood pressure resulting in symptomatic end-organ injury

A hypertensive emergency is very high blood pressure with potentially life-threatening symptoms and signs of acute damage to one or more organ systems. It is different from a hypertensive urgency by this additional evidence for impending irreversible hypertension-mediated organ damage (HMOD). Blood pressure is often above 200/120 mmHg, however there are no universally accepted cutoff values. Signs of organ damage are discussed below.

<span class="mw-page-title-main">Hypertensive heart disease</span> Medical condition

Hypertensive heart disease includes a number of complications of high blood pressure that affect the heart. While there are several definitions of hypertensive heart disease in the medical literature, the term is most widely used in the context of the International Classification of Diseases (ICD) coding categories. The definition includes heart failure and other cardiac complications of hypertension when a causal relationship between the heart disease and hypertension is stated or implied on the death certificate. In 2013 hypertensive heart disease resulted in 1.07 million deaths as compared with 630,000 deaths in 1990.

<span class="mw-page-title-main">Restrictive cardiomyopathy</span> Medical condition

Restrictive cardiomyopathy (RCM) is a form of cardiomyopathy in which the walls of the heart are rigid. Thus the heart is restricted from stretching and filling with blood properly. It is the least common of the three original subtypes of cardiomyopathy: hypertrophic, dilated, and restrictive.

<span class="mw-page-title-main">Nebivolol</span> Chemical compound

Nebivolol is a beta blocker used to treat high blood pressure and heart failure. As with other β-blockers, it is generally a less preferred treatment for high blood pressure. It may be used by itself or with other blood pressure medication. It is taken by mouth.

<span class="mw-page-title-main">Takotsubo cardiomyopathy</span> Sudden temporary weakening of the heart muscle

Takotsubo cardiomyopathy or takotsubo syndrome (TTS), also known as stress cardiomyopathy, is a type of non-ischemic cardiomyopathy in which there is a sudden temporary weakening of the muscular portion of the heart. It usually appears after a significant stressor, either physical or emotional; when caused by the latter, the condition is sometimes called broken heart syndrome. Examples of physical stressors that can cause TTS are sepsis, shock, subarachnoid hemorrhage, and pheochromocytoma. Emotional stressors include bereavement, divorce, or the loss of a job. Reviews suggest that of patients diagnosed with the condition, about 70–80% recently experienced a major stressor, including 41–50% with a physical stressor and 26–30% with an emotional stressor. TTS can also appear in patients who have not experienced major stressors.

<span class="mw-page-title-main">Tricuspid regurgitation</span> Type of valvular heart disease

Tricuspid regurgitation (TR), also called tricuspid insufficiency, is a type of valvular heart disease in which the tricuspid valve of the heart, located between the right atrium and right ventricle, does not close completely when the right ventricle contracts (systole). TR allows the blood to flow backwards from the right ventricle to the right atrium, which increases the volume and pressure of the blood both in the right atrium and the right ventricle, which may increase central venous volume and pressure if the backward flow is sufficiently severe.

<span class="mw-page-title-main">Noncompaction cardiomyopathy</span> Congenital disease of heart muscle

Noncompaction cardiomyopathy (NCC) is a rare congenital disease of heart muscle that affects both children and adults. It results from abnormal prenatal development of heart muscle.

The following outline is provided as an overview of and topical guide to cardiology, the branch of medicine dealing with disorders of the human heart. The field includes medical diagnosis and treatment of congenital heart defects, coronary artery disease, heart failure, valvular heart disease and electrophysiology. Physicians who specialize in cardiology are called cardiologists.

<span class="mw-page-title-main">Complications of hypertension</span>

Complications of hypertension are clinical outcomes that result from persistent elevation of blood pressure. Hypertension is a risk factor for all clinical manifestations of atherosclerosis since it is a risk factor for atherosclerosis itself. It is an independent predisposing factor for heart failure, coronary artery disease, stroke, kidney disease, and peripheral arterial disease. It is the most important risk factor for cardiovascular morbidity and mortality, in industrialized countries.

A diagnosis of myocardial infarction is created by integrating the history of the presenting illness and physical examination with electrocardiogram findings and cardiac markers. A coronary angiogram allows visualization of narrowings or obstructions on the heart vessels, and therapeutic measures can follow immediately. At autopsy, a pathologist can diagnose a myocardial infarction based on anatomopathological findings.

Ola (Olakunle) Akinboboye is a Nigerian-American nuclear cardiologist.

<span class="mw-page-title-main">Ischemic cardiomyopathy</span> Medical condition

Ischemic cardiomyopathy is a type of cardiomyopathy caused by a narrowing of the coronary arteries which supply blood to the heart. Typically, patients with ischemic cardiomyopathy have a history of acute myocardial infarction, however, it may occur in patients with coronary artery disease, but without a past history of acute myocardial infarction. This cardiomyopathy is one of the leading causes of sudden cardiac death. The adjective ischemic means characteristic of, or accompanied by, ischemia — local anemia due to mechanical obstruction of the blood supply.

References

  1. "Celebrating former UI VC Falase at 70 - Daily Trust". dailytrust.com. Retrieved 2023-11-10.
  2. 1 2 Admin (2017-01-25). "FALASE, Prof. Ayodele Olajide". Biographical Legacy and Research Foundation. Retrieved 2019-06-08.
  3. "Afe Babalola, Falase, Edozien, others bag honorary doctorate". Tribune Online. 2019-11-19. Retrieved 2023-11-10.
  4. "I became a professor against my wish". The Nation Newspaper. 2014-01-03. Retrieved 2019-06-08.
  5. "Nigerian National Merit Award". www.meritaward.ng. Retrieved 2021-02-10.
  6. "Clinical – UCH IBADAN".
  7. "An Introduction to Clinical Diagnosis in the Tropics (January 1, 2000 edition) | Open Library".
  8. Falase AO. Endomyocardial fibrosis in Africa. Postgraduate Medical Journal. 1983 Mar 1;59(689):170-8.
  9. Falase AO, Ogah OS. Cardiomyopathies and myocardial disorders in Africa: present status and the way forward. Cardiovascular journal of Africa. 2012 Nov;23(10):552.
  10. Falase AO, Kolawole TM, Lagundoye SB. Endomyocardial fibrosis. Problems in differential diagnosis. Heart. 1976 Apr 1;38(4):369-74.
  11. "Ayodele Olajide Falaise's research works | University College Hospital Ibadan, Ibadan and other places". ResearchGate. Retrieved 2019-06-08.
  12. Falase, Ayodele Olajide (1985-03-01). "Infections and dilated cardiomyopathy in Nigeria". Heart and Vessels. 1 (1): 40–44. doi:10.1007/BF02072358. ISSN   1615-2573. PMID   3038833. S2CID   28259042.
  13. Ogah OS, Okpechi I, Chukwuonye II, Akinyemi JO, Onwubere BJ, Falase AO, Stewart S, Sliwa K. Blood pressure, the prevalence of hypertension and hypertension-related complications in Nigerian Africans: A review. World journal of cardiology. 2012 Dec 26;4(12):327.
  14. Aje A, Adebiyi AA, Oladapo OO, Dada A, Ogah OS, Ojji DB, Falase AO. Left ventricular geometric patterns in newly presenting Nigerian hypertensives: An echocardiographic study. BMC Cardiovascular Disorders. 2006 Dec 1;6(1):4.
  15. Oladapo OO, Salako L, Sadiq L, Soyinka K, Falase AO. Knowledge of hypertension and other risk factors for heart disease among Yoruba rural southwestern Nigerian population. Journal of Advances in Medicine and Medical Research. 2013 Mar 13:993-1003.
  16. Olubodun JO, Falase AO, Cole TO. Drug compliance in hypertensive Nigerians with and without heart failure. International journal of cardiology. 1990 May 1;27(2):229-34.
  17. Ojji DB, Alfa J, Ajayi SO, Mamven MH, Falase AO. Pattern of heart failure in Abuja, Nigeria: an echocardiographic study. Cardiovascular journal of Africa. 2009 Dec;20(6):349.
  18. Ogah OS, Stewart S, Falase AO, Akinyemi JO, Adegbite GD, Alabi AA, Ajani AA, Adesina JO, Durodola A, Sliwa K. Contemporary profile of acute heart failure in Southern Nigeria: data from the Abeokuta Heart Failure Clinical Registry. JACC: Heart Failure. 2014 Jun 1;2(3):250-9.
  19. Falase AO, Ayeni O, Sekoni GA, Odia OJ. Heart failure in Nigerian hypertensives. African journal of medicine and medical sciences. 1983 Mar;12(1):7-15.
  20. Falase AO, Cole TO, Osuntokun BO. Myocardial infarction in Nigerians. Tropical and geographical medicine. 1973;25(2):147-50.
  21. Falase AO, Oladapo OO, Kanu EO. Relatively low incidence of myocardial infarction in Nigerians. Cardiologie tropicale. 2001;27(107):45-7.
  22. Ogah OS, Adebayo O, Aje A, Koya FK, Towoju O, Adesina JO, Adeoye AM, Adebiyi AA, Oladapo OO, Falase AO. Isolated left ventricular noncompaction: Report of a case from Ibadan, Nigeria. Nigerian Journal of Cardiology. 2016 Jul 1;13(2):148.
  23. OpenLibrary.org. "An Introduction to Clinical Diagnosis in the Tropics (January 1, 2000 edition) | Open Library". Open Library. Retrieved 2021-02-10.